/ 100
Bafna Pharmaceuticals Limited (BAFNAPH) — Technical Setup
₹317.20 +1.99% Strong Uptrend Volatility Expansion Strong bullish
Summary
Bafna Pharmaceuticals Limited is in a strong uptrend on the daily chart, with the weekly trend bullish and the monthly trend bullish. RSI(14) is 68.1, MACD is below its signal line, ADX reads 31 (trending). The stock trades 85.5% above its 200-day average and 0.4% below its 52-week high. Volume in the latest session was 0.5× its 20-day average. Over three months it has outperformed the Nifty 50 by 91.7 percentage points. Nearest support is ₹295.60 and resistance ₹318.50. Its technical score is 84/100 (strong bullish).
🧮 How the 84/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (7.18)3/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA3/3
- Close above 200-day SMA (85.53)3/3
- SuperTrend (10,3) pointing up3/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (30.52)3/3
- Weekly trend up (above a rising 30-week average)2/2
- RSI(14) in the bullish zone (55-70 best) (68.13)6/6
- MACD line above its signal line0/4
- MACD line above zero (14.21)3/3
- 12-day rate of change positive (1.47)3/3
- Stochastic %K above %D2/2
- Outperforming the Nifty 50 over 3 months (91.73)2/2
- On-balance volume rising over 20 sessions5/5
- Chaikin Money Flow (20) positive (0.56)5/5
- More volume on up days than down days (20 sessions) (3.47)5/5
- Close above 20-day VWAP (9.41)5/5
- Daily range (ATR%) contained — ≤2.5% scores full (2.34)6/6
- Price in the upper half of its Bollinger Bands (0.78)5/5
- Shallow drawdown from the 52-week high (-0.41)5/5
- Volatility contracting (20-day volatility below its 6-month median) (32.80)4/4
- Room to the next resistance (≥8% scores full) (0.41)0/5
- Support close below (a tight, definable stop) (6.81)3/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-0.41)5/5
🧭 Regime: Strong Uptrend
Volatility Expansion — Bollinger width is in the 44th percentile of the last six months.
Suits: Trend-following. Pullbacks to the 20-day EMA and breakouts tend to be bought in strong trends; mean-reversion shorts fight the tape.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the Momentum Breakout rules for BAFNAPH — close at a 20-day high on 1.5× average volume, rsi above 55.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | ▲ Bullish | 79.71 | 20.98 |
| Weekly | ▲ Bullish | 74.19 | 8.74 |
| Daily | ▲ Bullish | 68.13 | -0.12 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 47.02.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks.
💪 Relative strength
BAFNAPH ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming. The RS line is at a 52-week high.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹318.50 | +0.4% | 1 |
| Close | ₹317.20 | — | |
| Support | ₹295.60 | −6.8% | 1 |
| Support | ₹290.70 | −8.3% | 1 |
| Support | ₹232.95 | −26.6% | 1 |
| Support | ₹227.00 | −28.4% | 1 |
52-week range: ₹94.77 – ₹318.50 (-0.41% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹107.99 (2026-03-25) to ₹318.50 (2026-09-01). Price has retraced 0.6% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹268.82 | -15.2% | nearest |
| 38.2% retracement | ₹238.09 | -24.9% | |
| 50.0% retracement | ₹213.24 | -32.8% | |
| 61.8% retracement | ₹188.40 | -40.6% | |
| 78.6% retracement | ₹153.04 | -51.8% | |
| 127.2% extension | ₹375.76 | +18.5% | |
| 161.8% extension | ₹448.60 | +41.4% | |
| 200.0% extension | ₹529.01 | +66.8% |
🕯️ Candlesticks (last 5 sessions)
- Dragonfly Doji 2026-09-15 bullish Strong · 70
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
✅ Screens BAFNAPH passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| AUROPHARMAAurobindo Pharma Limited | ₹1,734 | +2.60% | 94 | Uptrend | 84.00 |
| AAREYDRUGSAarey Drugs & Pharmaceuticals Limited | ₹102.13 | +0.40% | 85 | Strong Uptrend | 86.00 |
| ACUTAASAcutaas Chemicals Limited | ₹3,440 | +3.78% | 85 | Uptrend | 93.00 |
| KOPRANKopran Limited | ₹277.60 | +3.35% | 85 | Strong Uptrend | 96.00 |
| KILITCHKilitch Drugs (India) Limited | ₹191.45 | +1.47% | 84 | Uptrend | 63.00 |
| CAPLIPOINTCaplin Point Laboratories Limited | ₹2,749 | +5.85% | 83 | Uptrend | 83.00 |
| GLANDGland Pharma Limited | ₹2,962 | +1.86% | 83 | Strong Uptrend | 91.00 |
| JUBLPHARMAJubilant Pharmova Limited | ₹1,065 | +5.27% | 80 | Strong Uptrend | 64.00 |
| STARStrides Pharma Science Limited | ₹1,220 | +1.63% | 80 | Strong Uptrend | 81.00 |
| ZIMLABZim Laboratories Limited | ₹135.51 | -1.75% | 80 | Strong Uptrend | 92.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
